Hier wordt bevestigd dat het inderdaad om een topical met TB4 gaat.
The licensed technology offers a new and potential effective treatment for hair loss. In
particular, the technology provides compositions comprising thymosin β4 and actin-binding
peptides that are suitable as topical application for the treatment of alopecia and other
conditions associated with hair loss. It describes the novel use of naturally occurring,
actin-binding peptides to activate hair follicles. In animal studies, topical application of such
peptides increased the number of active hair follicles at least two-fold. After application three
times a week, new hair growth was observed as early as on day 7, and was retained with
additional applications. This technology may lead to a treatment for a condition that affects a
large percentage of the population. A patent application of this technology has been filed with
the US Patent Office on 25 January 2002.
Er staat dat Lee's Pharma dit doet in overeenstemming met de NIH, de instantie waar ook de FDA onder valt enzo.
Hoe kan zoiets als RegeneRx een patent erop heeft? Snapt iemand dit?
Overigens is iedereen uitgenodigd te helpen zoeken op amerikaanse forums!
